Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-12-22
|
pubmed:abstractText |
Three variants of the human monoblastic cell line U937 with different degrees of sensitivity to the antiproliferative action of interferon-alpha (IFN-alpha were examined for phenotypic differences. The highly IFN-sensitive variant U937-V expressed twice as many IFN-alpha binding sites as both its IFN-alpha-resistant derivative U937-VR and the cell line U937 exhibiting a 20-fold reduction in IFN-alpha sensitivity as compared to U937-V cells. All three variants were IFN-reactive with regard to induction of 2',5'-oligoadenylate (2-5A) synthetase activity and were similarly sensitive to the growth-inhibiting action of IFN-gamma and tumor necrosis factor. Responsiveness to the antiproliferative effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), however, was confined to cell lines U937 and U937-VR. Although expressing a comparable number of GM-CSF receptors, the highly IFN-sensitive variant U937-V was refractory to GM-CSF. Flow cytometry revealed a marked difference in the expression of the antigen CD11b which was detectable on 85% of cells of the U937-V line but only on approximately 25% of cells derived from the U937 and U937-VR lines. Results thus demonstrate opposite sensitivity of U937 cells to the growth-inhibiting action of IFN-alpha and GM-CSF, apparently dependent on the state of U937 differentiation as determined by expression of the CD11b antigen.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2',5'-Oligoadenylate Synthetase,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte-Macrophage...,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interferon,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0197-8357
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
369-76
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:1431316-2',5'-Oligoadenylate Synthetase,
pubmed-meshheading:1431316-Cell Differentiation,
pubmed-meshheading:1431316-Cell Division,
pubmed-meshheading:1431316-Enzyme Induction,
pubmed-meshheading:1431316-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:1431316-Humans,
pubmed-meshheading:1431316-Infant, Newborn,
pubmed-meshheading:1431316-Interferon-alpha,
pubmed-meshheading:1431316-Interferon-gamma,
pubmed-meshheading:1431316-Leukemia, Monocytic, Acute,
pubmed-meshheading:1431316-Phenotype,
pubmed-meshheading:1431316-Protein Binding,
pubmed-meshheading:1431316-Receptors, Interferon,
pubmed-meshheading:1431316-Sensitivity and Specificity,
pubmed-meshheading:1431316-Tumor Cells, Cultured,
pubmed-meshheading:1431316-Tumor Necrosis Factor-alpha
|
pubmed:year |
1992
|
pubmed:articleTitle |
Opposite sensitivity to the antiproliferative action of interferon-alpha and granulocyte-macrophage colony-stimulating factor in monoblastic U937 cells.
|
pubmed:affiliation |
Department of Internal Medicine (Cancer Research), West German Cancer Center, University of Essen Medical School.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|